| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2025-06-26 | Cidara Therapeutics, Inc. | Shah Rajeev M.
(Director) |
P | Common Stock | A | 2272727 | $44.00 - $44.00 | $99,999,988 |
| 2025-06-30 | Kymera Therapeutics, Inc. | BAKER JULIAN
(Director) |
P | Common Stock | A | 655500 | $44.00 - $44.00 | $28,842,000 |
| 2025-06-26 | 5C Lending Partners Corp. | LIBERTY MUTUAL IN...
(AtLeastTenPercentOwner) |
P | Common Stock, par value $0.001 per share | A | 781355 | $24.73 - $24.73 | $19,322,908 |
View all insider buyers in week of 06/29/2025.
View Largest insider buying & Selling in the week of 06/22/2025.
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2025-06-27 | ORACLE CORP | CATZ SAFRA
(Chief Executive Officer) |
S | Common Stock | D | 1260508 | $210.35 - $214.25 | $267,244,337 |
| 2025-06-26 | Snowflake Inc. | Slootman Frank
(Director) |
S | Class A Common Stock | D | 731354 | $216.30 - $224.15 | $161,374,977 |
| 2025-06-27 | BridgeBio Pharma, Inc. | Shabet Rose Sharon
(AtLeastTenPercentOwner) |
S | Common Stock | D | 3500000 | $44.00 - $44.00 | $154,000,000 |
View all insider sellers in week of 06/29/2025.
View Largest insider buying & Selling in the week of 06/22/2025.
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |